This was a quasi-experimental single-group study conducted in spring 2018 on hemodialysis patients in Ali-bin Abitaleb teaching hospital. A total of 32 patients with type 2 diabetes, who had been admitted for hemodialysis and had the inclusion criteria were chosen as the study population via convenience sampling. The inclusion criteria were a history of dialysis for at least three months, no use of blood pressure reducers, weight gain up to 3 kg between hemodialysis sessions, and lack of anemia, malignant diseases, or thyroid disorders. Patients, who expressed their willingness to participate, were provided with necessary explanations regarding the procedure and purpose of the study. Besides, they were required to hand in their informed consent form. This research was approved by the Ethics Committee of Zahedan University of Medical Sciences and registered under the code of IR. ZAUMS. REC.1396.292. It fulfilled the ethical considerations of medical research, including confidentiality of patients’ information.
Patient registration form consisted of two parts. The first part covered demographic and clinical characteristics, including age, gender, marital status, education, occupation, weight, underlying disease, residence, vital signs, hemodialysis onset, hemodialysis frequency per week, hemodialysis length in each session (hour), duration of diabetes (year), duration of treatment with hemodialysis (month), weight loss during hemodialysis, results of blood tests, type of dialysis filter and solution based on examination, surveying the cases, and interviewing patients. The second part included measuring and ensuring the adequacy of dialysis of each patient during each session. The sample size was estimated at 14 by means of the following formula and taking in account the numerical values of the variables discussed by Beladi Mousavi et al., along with the confidence interval and test power of 95%. However, to ensure the adequacy of sample size, it was set at 30. Finally, considering the possible dropout and to obtain a greater certainty, 32 subjects were selected to be studied (
20).
The study was performed in two stages. Initially, all patients underwent hemodialysis with the solution being set at 37°C (i.e., the routine solution, which is the usual hemodialysis temperature). Next, they were exposed to reduced dialysate temperature of 36°C (the cold solution). The sequence of dialysis with cold or routine solutions for each patient was randomly determined using a blue and a green ball, so that each patient was asked to choose a ball from a box containing 16 blue balls and 16 green balls. In the first stage, the blue and green balls were used to signify the cold and routine solutions, respectively. This was reversed in the second stage.
In order to provide identical conditions, hemodialysis variables were the same in both cases, except for the solution temperature. All patients were dialyzed three times per week for three to four hours each session. The average body temperature of patients was set at 37°C before hemodialysis. For all patients, R5 polysulfone dialyzers (Soha Co.) were used with the same high-flux ultrafiltration coefficient and bicarbonate hemodialysis solution (bicarbonate sodium 650 g 35 Meql/L, Pharmed Medical Industries co.), which was fixed during the study. All instruments, including dialysis machines equipped with ultrafiltration control system (Fresenius model 4008-B), scale (Seca), and pressure gauge were tested and approved. Dialysate flow rate was constant at 500 mg/minute. The rate of fluid harvest for each patient was calculated based on the difference in weight before dialysis and after dialysis (i.e. dry weight). The blood flow was calculated at 300 mL/minute, and needle tip size 16 was used.
All parameters were maintained on the device until the end of the dialysis session. To measure BUN before dialysis, arterial blood sample was immediately collected before hemodialysis. After the end of the hemodialysis session, to prepare the blood sample, the pump flow was first reduced to 100 cc/minute. After 15 seconds, another arterial sample was collected. All samples were evaluated by the hospital laboratory, and the results were collected. Once the samples were measured, dialysis adequacy was assessed through the Kt/V method, using the Daugirdas II formula, which is internationally acceptable (
21). In this formula, Ln is the natural logarithm, R is the ratio of post-dialysis to pre-dialysis urea, T is the duration of each hemodialysis per hour, UF is the volume of ultrafiltration, and V is the post-dialysis weight (
22). The Kt/V index was equal to or more than 1.2 represented good dialysis and less than 1.2 indicated dialysis with poor adequacy. Thus, the more the Kt/V values exceeded 1.2, the greater the adequacy of dialysis would be. By the same token, even as this value recedes from 1.2, dialysis adequacy diminishes accordingly.
URR = BUNpre - BUNpost/BUNpost.100 (BUN = Blood urea nitrogen)
KT/V = - Ln (R - 0/008×T) + (4 - 3/5T)×0/55UF/V
KT/V = Ln (1 - URR)
Finally, the data were analyzed in SPSS 21. The descriptive statistics of mean, frequency, and standard deviation were used to describe the data. Subsequently, the effect of cold dialysis on the adequacy of dialysis was evaluated using the dependent t-test. The level of significance was considered below 0.05.